2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430 · see citing works

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,119 · see citing works

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879 · see citing works

Edoxaban versus warfarin in patients with atrial fibrillation

Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164 · see citing works

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051 · see citing works

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · see citing works

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517 · see citing works

Clinical Practice Guidelines We Can Trust

Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,102 · see citing works

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,906 · see citing works

Catheter Ablation for Atrial Fibrillation with Heart Failure

MARROUCHE, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L. V. A., Jordaens, L. J. L. M., Merkely, B. P., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,514 · see citing works

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,506 · see citing works

Apixaban in patients with atrial fibrillation

Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · see citing works

Cryptogenic stroke and underlying atrial fibrillation

Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161 · see citing works

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · see citing works

Subclinical atrial fibrillation and the risk of stroke

Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100 · see citing works

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

Holmes, D. R., Kar, S., Price, M. J., Whisenant, B. K., Sievert, H., Doshi, S. K., Huber, K., & Reddy, V. Y. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.029 · Cited by 1,850 · see citing works

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Dewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62177-1 · Cited by 1,719 · see citing works

Prevention of bleeding in patients with atrial fibrillation undergoing PCI

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590 · see citing works

Dabigatran versus warfarin in patients with mechanical heart valves

Eikelboom, J. W., Connolly, S. J., Brueckmann, M., Granger, C. B., Kappetein, A. P., Mack, M. J., Blatchford, J., Devenny, K., Friedman, J., Guiver, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300615 · Cited by 1,506 · see citing works

Obesity and the risk of new-onset atrial fibrillation

Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427 · see citing works

Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation

Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383 · see citing works

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501035 · Cited by 1,184 · see citing works

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J. W., Glund, S., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kam, C. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707278 · Cited by 1,148 · see citing works

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

Siegal, D. M., Curnutte, J. T., Connolly, S. J., Lu, G., Conley, P. B., Wiens, B. L., Mathur, V. S., Castillo, J., Bronson, M. D., Leeds, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510991 · Cited by 1,047 · see citing works

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

Pathak, R. K., Middeldorp, M. E., Meredith, M., Mehta, A. B., Mahajan, R., Wong, C. X., Twomey, D., Elliott, A. D., Kalman, J. M., Abhayaratna, W. P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.002 · Cited by 1,036 · see citing works

Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial

Reddy, V. Y., Sievert, H., Halperin, J., Doshi, S. K., Buchbinder, M., Neuzil, P., Huber, K., Whisenant, B., Kar, S., Swarup, V., et al. (2014) · JAMA · doi:10.1001/jama.2014.15192 · Cited by 1,018 · see citing works

Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation

Klein, A. L., Grimm, R. A., Murray, R. D., Apperson-Hansen, C., ASINGER, R. W., Black, I. W., Davidoff, R., Erbel, R., Halperin, J. L., Orsinelli, D. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441901 · Cited by 952 · see citing works

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

Pathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.028 · Cited by 949 · see citing works

Finding What Works in Health Care: Standards for Systematic Reviews

Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 943 · see citing works

Antithrombotic Therapy for Atrial Fibrillation

You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2304 · Cited by 924 · see citing works

Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves

Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briët, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 904 · see citing works

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device

Biase, L. D., Mohanty, P. K., Mohanty, S., Santangeli, P., Trivedi, C. G., Lakkireddy, D., Reddy, M., Jaı̈s, P., Themistoclakis, S., Russo, A. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019406 · Cited by 880 · see citing works

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study

Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879 · see citing works

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607887 · Cited by 804 · see citing works

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial

Abed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.280521 · Cited by 776 · see citing works

Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750 · see citing works

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

Reddy, V. Y., Möbius-Winkler, S., Miller, M. A., Neuzil, P., Schuler, G., Wiebe, J., Sick, P., & Sievert, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.035 · Cited by 727 · see citing works

Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction

Prabhu, S., Taylor, A. J., Costello, B. T., Kaye, D. M., McLellan, A. J. A., Voskoboinik, A., Sugumar, H., Lockwood, S. M., Stokes, M. B., Pathik, B., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.041 · Cited by 661 · see citing works

Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study

Halcox, J. P. J., Wareham, K., Cardew, A., Gilmore, M., Barry, J. P., Phillips, C., & Gravenor, M. B. (2017) · Circulation · doi:10.1161/circulationaha.117.030583 · Cited by 580 · see citing works

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation

Holmes, D. R., Doshi, S. K., Kar, S., Price, M. J., Sanchez, J. M., Sievert, H., Valderrabano, M., & Reddy, V. Y. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.025 · Cited by 543 · see citing works

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

Nagarakanti, R., Ezekowitz, M. D., Oldgren, J., Yang, S., Chernick, M. R., Aikens, T. H., Flaker, G., Brugada, J., Kamenský, G., Parekh, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.977546 · Cited by 525 · see citing works

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry

Boersma, L. V. A., Schmidt, B., Betts, T. R., Sievert, H., Tamburino, C., Teíger, E., Pokushalov, E., Kische, S., Schmitz, T., Steín, K. M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv730 · Cited by 522 · see citing works

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 520 · see citing works

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States

Siontis, K. C., Zhang, X., Eckard, A., Bhave, N. M., Schaubel, D. E., He, K., Tilea, A. M., Stack, A. G., Balkrishnan, R., Yao, X., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035418 · Cited by 496 · see citing works

Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome

Wong, C. X. J., Abed, H. S., Molaee, P., Nelson, A. J., Brooks, A. G., Sharma, G., Leong, D. P., Lau, D. H., Middeldorp, M. E., Roberts‐Thomson, K. C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.045 · Cited by 494 · see citing works

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

Olesen, J. B., Torp-Pedersen, C. T., Hansen, M. L., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 484 · see citing works

Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study

Fang, M. C., Singer, D. E., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Go, A. S. (2005) · Circulation · doi:10.1161/circulationaha.105.553438 · Cited by 469 · see citing works

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

Fiedler, K. A., Maeng, M., Mehilli, J., Schulz-Schüpke, S., Byrne, R., Sibbing, D., Hoppmann, P., Schneider, S., Fusaro, M., Ott, I., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.050 · Cited by 454 · see citing works

Smartwatch Algorithm for Automated Detection of Atrial Fibrillation

Bumgarner, J. M., Lambert, C. T., Hussein, A. A., Cantillon, D. J., Baranowski, B., Wolski, K., Lindsay, B. D., Wazni, O. M., & Tarakji, K. G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.003 · Cited by 446 · see citing works

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Larsen, T. B., Skjøth, F., Nielsen, P. B., Kjældgaard, J. N., & Lip, G. Y. H. (2016) · BMJ · doi:10.1136/bmj.i3189 · Cited by 440 · see citing works

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

Boersma, L. V. A., Ince, H., Kische, S., Pokushalov, E., Schmitz, T., Schmidt, B., Gori, T., Meincke, F., Protopopov, A. V., Betts, T. R., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.038 · Cited by 433 · see citing works

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

Calkins, H. G., Willems, S., Gerstenfeld, E. P., Verma, A., SCHILLING, R. J., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701005 · Cited by 432 · see citing works

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)

Boriani, G., Glotzer, T. V., Santini, M., West, T. M., De Melis, M., Sepsi, M., Gasparini, M., Lewalter, T., Camm, J. A., & Singer, D. E. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht491 · Cited by 427 · see citing works

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yao, X., Abraham, N. S., Sangaralingham, L. R., Bellolio, F., McBane, R. D., Shah, N. D., & Noseworthy, P. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003725 · Cited by 421 · see citing works

Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1fn1This study was funded by grants from Genentech, South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Crenshaw, B. S., Ward, S. R., Granger, C. B., Stebbins, A., Topol, E. J., & Califf, R. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00194-0 · Cited by 403 · see citing works

Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation

Abed, H. S., Samuel, C. S., Lau, D. H., Kelly, D. J., Royce, S. G., Alasady, M., Mahajan, R., Kuklik, P., Zhang, Y., Brooks, A. G., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.043 · Cited by 401 · see citing works

PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study

Middeldorp, M. E., Pathak, R. K., Meredith, M., Mehta, A. B., Elliott, A. D., Mahajan, R., Twomey, D. J., Gallagher, C., Hendriks, J., Linz, D., et al. (2018) · EP Europace · doi:10.1093/europace/euy117 · Cited by 393 · see citing works

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

Cappato, R., Ezekowitz, M. D., Klein, A. L., Camm, A. J., Ma, C., Heuzey, J. L., Talajic, M. R., Scanavacca, M., Vardas, P. E., Kirchhof, P. F., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu367 · Cited by 371 · see citing works

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices

Martin, D. T., BERSOHN, M. M., Waldo, A. L., Wathen, M. S., Choucair, W. K., Lip, G. Y. H., Ip, J. E., Holcomb, R. G., Akar, J. G., & Halperin, J. L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv115 · Cited by 361 · see citing works

Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions

Wong, C. X. J., Ganesan, A. N., & Selvanayagam, J. B. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw045 · Cited by 351 · see citing works

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.

Lamberts, M., Gislason, G., Olesen, J., Kristensen, S., Olsen, A. S., Mikkelsen, A., Christensen, C. B., Lip, G., Køber, L., Torp-Pedersen, C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.029 · Cited by 350 · see citing works

Acute Myocardial Infarction Complicated by Atrial Fibrillation in the Elderly

Rathore, S. S., Berger, A. K., Weinfurt, K. P., Schulman, K. A., Oetgen, W. J., Gersh, B. J., & Solomon, A. J. (2000) · Circulation · doi:10.1161/01.cir.101.9.969 · Cited by 343 · see citing works

Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice: Insight From the Real-Life Global Survey Evaluating Patients With Atrial Fibrillation International Registry

Chiang, C.-E., Naditch-Brûlé, L., Murin, J., Goethals, M., Inoue, H., O’Neill, J., Silva-Cardoso, J., Zharinov, O., Gamra, H., Alam, S., et al. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.112.970749 · Cited by 327 · see citing works

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

Chan, K. E., Edelman, E. R., Wenger, J., Thadhani, R., & Maddux, F. W. (2015) · Circulation · doi:10.1161/circulationaha.114.014113 · Cited by 325 · see citing works

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

Graham, D. J., Reichman, M. E., Wernecke, M., Hsueh, Y.-H., Izem, R., Southworth, M. R., Wei, Y., Liao, J., Goulding, M. R., Mott, K., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5954 · Cited by 313 · see citing works

Digoxin-associated mortality: a systematic review and meta-analysis of the literature

Vámos, M., Erath, J. W., & Hohnloser, S. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv143 · Cited by 302 · see citing works

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Halperin, J. L., Levine, G. N., Al‐Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000312 · Cited by 293 · see citing works

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

McMurray, J., Køber, L., Robertson, M., Dargie, H., Colucci, W., López-Sendón, J., Remme, W., Sharpe, D., & Ford, I. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.076 · Cited by 291 · see citing works

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Bohula, E. A., Giugliano, R. P., Ruff, C. T., Kuder, J., Murphy, S. A., Antman, E. M., & D, E. B. M. (2016) · Circulation · doi:10.1161/circulationaha.116.022361 · Cited by 291 · see citing works

Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial

Puskas, J. D., Gerdisch, M., Nichols, D., Quinn, R. D., Anderson, C. C., Rhenman, B. E., Fermin, L., McGrath, M., Kong, B. K., Hughes, C. G., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.01.004 · Cited by 285 · see citing works

Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease

Bonde, A. N., Lip, G. Y. H., Kamper, A., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 284 · see citing works

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation

Winkelmayer, W. C., Liu, J., Setoguchi, S., & Choudhry, N. K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04550511 · Cited by 280 · see citing works

Effect of home testing of international normalized ratio on clinical events

Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002617 · Cited by 266 · see citing works

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Piccini, J. P., Stevens, S. R., Lokhnygina, Y., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.025 · Cited by 266 · see citing works

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

Keshishian, A. V., Kamble, S., Pan, X., Mardekian, J., Horblyuk, R. V., Hamilton, M., & Lip, G. Y. H. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-05-0403 · Cited by 266 · see citing works

Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation

Airaksinen, K. E. J., Grönberg, T., Nuotio, I., Nikkinen, M., Ylitalo, A., Biancari, F., & Hartikainen, J. E. K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.089 · Cited by 258 · see citing works

Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation

Reddy, V. Y., Gibson, D. N., Kar, S., O’Neill, W. W., Doshi, S. K., Horton, R., Buchbinder, M., Gordon, N. T., & Holmes, D. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.010 · Cited by 258 · see citing works

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

Aguilar, M. I., & Hart, R. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001927.pub2 · Cited by 253 · see citing works

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation

Nielsen, P. B., Skjøth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2018) · Circulation · doi:10.1161/circulationaha.117.029081 · Cited by 253 · see citing works

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

Goette, A., Merino, J. L., Ezekowitz, M. D., Zamoryakhin, D., Melino, M. R., Jin, J., Mercuri, M. F., GROSSO, M. A., Serrano-Fernandez, V., Al‐Saady, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31474-x · Cited by 249 · see citing works

Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation

Yao, X., Tangri, N., Gersh, B. J., Sangaralingham, L. R., Shah, N. D., Nath, K. A., & Noseworthy, P. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1087 · Cited by 249 · see citing works

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

Flaker, G., Lópes, R. D., Al‐Khatib, S. M., Hermosillo, A. G., Hohnloser, S. H., Tinga, B., Zhu, J., Mohan, P., Garcia, D. A., Bartúnek, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.062 · Cited by 239 · see citing works

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

Noseworthy, P. A., Yao, X., Abraham, N. S., Sangaralingham, L. R., McBane, R. D., & Shah, N. D. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.07.013 · Cited by 239 · see citing works

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation

Sarafoff, N., Martischnig, A., Wealer, J., Mayer, K., Mehilli, J., Sibbing, D., & Kastrati, A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.036 · Cited by 236 · see citing works

The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction

Pedersen, O. B. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1352 · Cited by 230 · see citing works

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

Mavrakanas, T. A., Samer, C. F., Nessim, S. J., Frisch, G., & Lipman, M. L. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016090980 · Cited by 229 · see citing works

AREVA: Multicenter Randomized Comparison of Low-Dose Versus Standard-Dose Anticoagulation in Patients With Mechanical Prosthetic Heart Valves

Acar, J., Iung, B., Boissel, J., Samama, M. M., Michel, P. L., Teppe, J. P., Pony, J. C., Breton, H., Thomas, D., Isnard, R., et al. (1996) · Circulation · doi:10.1161/01.cir.94.9.2107 · Cited by 227 · see citing works

AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions

Arnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Circulation · doi:10.1161/cir.0000000000000128 · Cited by 222 · see citing works

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

Abraham, N. S., Noseworthy, P. A., Yao, X., Sangaralingham, L. R., & Shah, N. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.12.018 · Cited by 219 · see citing works

Digoxin and Mortality in Patients With Atrial Fibrillation

Lópes, R. D., Rordorf, R., Ferrari, G. M. D., Leonardi, S., Thomas, L. E., WOJDYLA, D. M., Ridefelt, P., Lawrence, J. H., Caterina, R. D., Vinereanu, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.060 · Cited by 218 · see citing works

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

Ntaios, G., Papavasileiou, V., Makaritsis, K. P., Vemmos, K. N., Michel, P., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.117.017549 · Cited by 214 · see citing works

Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

Pancholy, S. B., Sharma, P. S., Pancholy, D. S., Patel, T. M., Callans, D. J., & Marchlinski, F. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.035 · Cited by 204 · see citing works

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation

Lau, W. C. Y., Chan, E. W., Cheung, C., Sing, C., Man, K. K. C., Lip, G. Y. H., Siu, C., Lam, J. K. Y., Lee, A. C. H., & Wong, I. C. K. (2017) · JAMA · doi:10.1001/jama.2017.1363 · Cited by 203 · see citing works

The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey

Jacobs, A. K., Anderson, J. L., & Halperin, J. L. (2014) · Circulation · doi:10.1161/cir.0000000000000090 · Cited by 189 · see citing works

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Hirsh, J., & Fuster, V. (1994) · Circulation · doi:10.1161/01.cir.89.3.1469 · Cited by 186 · see citing works

Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery

Friedman, D. J., Piccini, J. P., Wang, T., Zheng, J., Malaisrie, S. C., Holmes, D. R., Suri, R. M., Mack, M. J., Badhwar, V., Jacobs, J. P., et al. (2018) · JAMA · doi:10.1001/jama.2017.20125 · Cited by 186 · see citing works

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)

de Werf, F. V., Brueckmann, M., Connolly, S. J., Friedman, J. E., Granger, C. B., Härtter, S., Harper, R., Kappetein, A. P., Lehr, T., Mack, M. J., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.03.011 · Cited by 185 · see citing works

Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis

Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014) · QJM · doi:10.1093/qjmed/hcu054 · Cited by 176 · see citing works

Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion

Gallagher, M. M., Hennessy, B. J., Edvardsson, N. G., Hart, C., Shannon, M. S., OBEL, O. A., Al‐Saady, N., & Camm, A. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02052-1 · Cited by 174 · see citing works

Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: A community-wide perspective

Goldberg, R. J., Seeley, D. G., Becker, R. C., Brady, P. M., Chen, Z., Osganian, V., Gore, J. M., Alpert, J. S., & Dalen, J. E. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80227-3 · Cited by 174 · see citing works

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial

Ezekowitz, M. D., Pollack, C. V., Halperin, J. L., England, R. D., Nguyen, S. V., Spahr, J., Sudworth, M., Cater, N. B., Breazna, A., Oldgren, J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy148 · Cited by 169 · see citing works

Time to cardioversion for acute atrial fibrillation and thromboembolic complications

Nuotio, I., Hartikainen, J. E. K., Grönberg, T., Biancari, F., & Airaksinen, K. E. J. (2014) · JAMA · doi:10.1001/jama.2014.3824 · Cited by 167 · see citing works

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

Carnicelli, A., Caterina, R. D., Halperin, J. L., Renda, G., Ruff, C. T., Trevisan, M., Nordio, F., Mercuri, M. F., Antman, E. M., & Giugliano, R. P. (2017) · Circulation · doi:10.1161/circulationaha.116.026714 · Cited by 166 · see citing works

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

Ezekowitz, M. D., Nagarakanti, R., Noack, H., Brueckmann, M., Litherland, C., Jacobs, M., Clemens, A., Reilly, P. A., Connolly, S. J., Yusuf, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020950 · Cited by 163 · see citing works

Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement

Hering, D., Piper, C., Bergemann, R., Hillenbach, C., Dahm, M., Huth, C., & Horstkotte, D. (2005) · CHEST Journal · doi:10.1378/chest.127.1.53 · Cited by 153 · see citing works

Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality

Melduni, R. M., Schaff, H. V., Lee, H.-C., Gersh, B. J., Noseworthy, P. A., Bailey, K. R., Ammash, N. M., Cha, S. S., Fatema, K., Wysokiński, W. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021952 · Cited by 151 · see citing works

Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis

Pan, K., Singer, D. E., Ovbiagele, B., Wu, Y., Ahmed, M., & Lee, M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005835 · Cited by 151 · see citing works

Dose-Finding Study of Rivaroxaban in Hemodialysis Patients

Vriese, A. S. D., Caluwé, R., Bailleul, E., Bacquer, D. D., Borrey, D., Vlem, B. V., Vandecasteele, S. J., & Emmerechts, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.022 · Cited by 150 · see citing works

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design

Packer, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Moretz, K., Poole, J. E., Mascette, A. M., Rosenberg, Y., Jeffries, N. O., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.02.015 · Cited by 147 · see citing works

Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study

MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137 · see citing works

Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction

Behar, S., ZAHAVI, Z., Goldbourt, U., Reicher-Reiss, H., & THE SPRINT SUDY GROUP (see Appendix) (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060046 · Cited by 136 · see citing works

Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study

Jaber, W. A., Prior, D., Thamilarasan, M., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106648 · Cited by 133 · see citing works

Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis

Dias, C. S., Moore, K. T., Murphy, J., Ariyawansa, J., Smith, W. B., Mills, R. M., & Weir, M. R. (2016) · American Journal of Nephrology · doi:10.1159/000445328 · Cited by 133 · see citing works

Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation

Mason, P. K., Lake, D. E., Dimarco, J., Ferguson, J., Mangrum, J. M., Bilchick, K. C., Moorman, L. P., & Moorman, J. R. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.030 · Cited by 130 · see citing works

Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation

Quinn, G. R., Severdija, O. N., Chang, Y., & Singer, D. E. (2016) · Circulation · doi:10.1161/circulationaha.116.024057 · Cited by 128 · see citing works

Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment

Gengler, B. E., Barasch, N. S., & Tellor, K. B. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1905 · Cited by 121 · see citing works

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

Reed, D. R., Palkimas, S., Hockman, R. H., Abraham, S., Le, T. M., & Maitland, H. S. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12083 · Cited by 110 · see citing works

The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial

Holmes, D. R., Reddy, V. Y., Buchbinder, M., Steín, K. M., Elletson, M., Bergmann, M., Schmidt, B., & Saw, J. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.03.007 · Cited by 106 · see citing works

ACCF/AHA Clinical Practice Guideline Methodology Summit Report

Jacobs, A. K., Kushner, F. G., Ettinger, S. M., Guyton, R. A., Anderson, J. L., Ohman, E. M., Albert, N. M., Antman, E. M., Arnett, D. K., Bertolet, M. H., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31827e8e5f · Cited by 104 · see citing works

Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy

Jackson, L. R., Ju, C., Zettler, M., Messenger, J. C., Cohen, D. J., Stone, G. W., Baker, B. A., Effron, M., Peterson, E. D., & Wang, T. Y. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.08.018 · Cited by 97 · see citing works

Dabigatran Etexilate in Atrial Fibrillation Patients With Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation

Lehr, T., Haertter, S., Liesenfeld, K., Staab, A., Clemens, A., Reilly, P. A., & Friedman, J. E. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011417716 · Cited by 96 · see citing works

One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

Rubboli, A., Schlitt, A., Kiviniemi, T., Biancari, F., Karjalainen, P., Valencia, J., Laine, M., Kirchhof, P., Niemelä, M., Vikman, S., et al. (2014) · Clinical Cardiology · doi:10.1002/clc.22254 · Cited by 95 · see citing works

Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment

Hariharan, S., & Madabushi, R. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011415527 · Cited by 85 · see citing works

Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation

Kent, A. P., Brueckmann, M., Fraessdorf, M., Connolly, S. J., Yusuf, S., Eikelboom, J. W., Oldgren, J., Reilly, P. A., Wallentin, L. C., & Ezekowitz, M. D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.063 · Cited by 84 · see citing works

Prevalence of Left Atrial Thrombus and Dense Spontaneous Echo Contrast in Patients With Short-Term Atrial Fibrillation < 48 Hours Undergoing Cardioversion: Value of Transesophageal Echocardiography to Guide Cardioversion

Kleemann, T., Becker, T., Strauss, M., Schneider, S., & Seidl, K. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.09.015 · Cited by 75 · see citing works

Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation

Flaker, G. C., Ezekowitz, M. D., Yusuf, S., Wallentin, L. C., Noack, H., Brueckmann, M., Reilly, P. A., Hohnloser, S. H., & Connolly, S. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.896 · Cited by 71 · see citing works

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients

Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.092 · Cited by 68 · see citing works

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Id, P. (2013) · Cited by 68 · see citing works

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

Biase, L. D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002776 · Cited by 65 · see citing works

Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA 2 DS 2 -VASc Risk Factor Be Anticoagulated?

Fauchier, L., Clémenty, N., Bisson, A., Ivanés, F., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016) · Stroke · doi:10.1161/strokeaha.116.013253 · Cited by 65 · see citing works

Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome

Braun, O. Ö., Bico, B., Chaudhry, U. A., Wagner, H., Koul, S. M., Tydén, P., Scherstén, F., Jovinge, S. V., Svensson, P. J., Smith, J. G., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.016 · Cited by 60 · see citing works

The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going

Khoury, T., Ayman, A. R., Cohen, J., et al. (2016) · Digestion · doi:10.1159/000442877 · Cited by 58 · see citing works

Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48

Plitt, A., Ezekowitz, M. D., Caterina, R. D., Nordio, F., Peterson, N., Giugliano, R. P., & on behalf of the ENGAGE AF‐TIMI 48 Investigators (2016) · Clinical Cardiology · doi:10.1002/clc.22537 · Cited by 58 · see citing works

Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset

Garg, A., Khunger, M., Seicean, S., Chung, M. K., & TCHOU, P. J. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.01.018 · Cited by 58 · see citing works

The Intersection of Risk and Benefit

Sood, M. M., Komenda, P. V. J., Sood, A. R., Rigatto, C., & Bueti, J. (2009) · CHEST Journal · doi:10.1378/chest.09-0730 · Cited by 53 · see citing works

Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis

Nochaiwong, S., Ruengorn, C., Awiphan, R., Dandecha, P., Noppakun, K., & Phrommintikul, A. (2016) · Open Heart · doi:10.1136/openhrt-2016-000441 · Cited by 52 · see citing works

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

Fanola, C. L., Giugliano, R. P., Ruff, C. T., Trevisan, M., Nordio, F., Mercuri, M. F., Antman, E. M., & D, E. B. M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw565 · Cited by 47 · see citing works

Indications for anticoagulant and antiplatelet combined therapy

Floyd, C. N., & Ferro, A. (2017) · BMJ · doi:10.1136/bmj.j3782 · Cited by 44 · see citing works

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation

Ahmad, Y., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.148 · Cited by 43 · see citing works

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

Pallisgaard, J. L., Lindhardt, T. B., Hansen, M. L., Schjerning, A.-M., Olesen, J. B., Stærk, L., Torp-Pedersen, C. T., & Gislason, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141377 · Cited by 38 · see citing works

Is Discharge to Home After Emergency Department Cardioversion Safe for the Treatment of Recent-Onset Atrial Fibrillation?

von Besser, K., & Mills, A. M. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.06.014 · Cited by 37 · see citing works

Prevention of stroke in patients with atrial fibrillation: current strategies and future directions

Hohnloser, S. H., Duray, G. Z., Baber, U., & Halperin, J. L. (2008) · European Heart Journal Supplements · doi:10.1093/eurheartj/sun029 · Cited by 34 · see citing works

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring

Ezekowitz, M. D., James, K. E., Radford, M. J., et al. (1999) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424849900400102 · Cited by 30 · see citing works

Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

Koskinas, K. C., Räber, L., Zanchin, T., Pilgrim, T., Stortecky, S., Hunziker, L., Blöchlinger, S., Billinger, M., Gartwyl, F., Moro, C., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.04.027 · Cited by 30 · see citing works

Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting

Fauchier, L., Lecoq, C., Ancédy, Y., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.06.018 · Cited by 28 · see citing works

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban

Bai, Y., Shi, X.-B., Ma, C., & Lip, G. Y. H. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.072 · Cited by 28 · see citing works

Apixaban Use Among Patients With Severe Renal Impairment

Deal, E. N., Pope, H. E., & Ross, W. R. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014554446 · Cited by 26 · see citing works

Abstract 17277: Apixaban Use in Patients With Atrial Fibrillation With Bioprosthetic Valves: Insights From ARISTOTLE

Pokorney, S. D., Rao, M. P., WOJDYLA, D. M., et al. (2015) · Circulation · doi:10.1161/circ.132.suppl_3.17277 · Cited by 24 · see citing works

Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature

Dentali, F., Botto, G. L., Gianni, M., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.096 · Cited by 22 · see citing works

Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study

Bah, A., Nuotio, I. O., Grönberg, T., et al. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1267869 · Cited by 17 · see citing works

Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?

Álvarez, B. Á., Raposeiras‐Roubín, S., Abu-Assi, E., et al. (2014) · Open Heart · doi:10.1136/openhrt-2014-000123 · Cited by 12 · see citing works

CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis

Philippart, R., Brunet-Bernard, A., Clémenty, N., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.061 · Cited by 11 · see citing works

Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED

Rivera‐Caravaca, J. M., Roldán, V., Esteve‐Pastor, M. A., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.11.004 · Cited by 8 · see citing works

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686 · see citing works

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473 · see citing works

2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association

Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237 · see citing works

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922 · see citing works

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association

Bozkurt, B., Coats, A. J. S., Tsutsui, H., Abdelhamid, C. M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2115 · Cited by 1,665 · see citing works

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines

Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association

Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405 · see citing works

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132 · see citing works

Heart Failure With Preserved Ejection Fraction: A Review

Redfield, M. M., & Borlaug, B. A. (2023) · JAMA · doi:10.1001/jama.2023.2020 · Cited by 662 · see citing works

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease

Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial

Zelniker, T. A., Bonaca, M. P., Furtado, R. H. M., Mosenzon, O., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044183 · Cited by 459 · see citing works

Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development

Holmes, M. V., Richardson, T. G., Ference, B. A., Davies, N. M., & Davey Smith, G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00493-1 · Cited by 184 · see citing works

Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association

Noseworthy, P. A., Kaufman, E. S., Chen, L. Y., Chung, M. K., Elkind, M. S. V., Joglar, J. A., Leal, M. A., McCabe, P. J., Pokorney, S. D., Yao, X., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000740 · Cited by 171 · see citing works

2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society

Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74 · see citing works

The Apple Watch can detect atrial fibrillation: so what now?

Marcus, G. M. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0330-y · Cited by 34 · see citing works

Procedural outcomes and learning curve of cardiac arrhythmias catheter ablation using remote magnetic navigation: Experience from a large-scale single-center study

Li, X., Jin, Q., Zhang, N., Ling, T., Lin, C., Jia, K., Bao, Y., Xie, Y., Wei, Y., Chen, K., et al. (2020) · Clinical Cardiology · doi:10.1002/clc.23391 · Cited by 16 · see citing works

Clinical Practice Guideline for Soeumin Disease of Sasang Constitutional Medicine: Overview

Lee, E.-J., Koh, B., Kim, D.-R., et al. (2014) · Journal of Sasang Constitutional Medicine · doi:10.7730/jscm.2014.26.1.001 · Cited by 11 · see citing works

Diagnosis and treatment of pediatric flatfoot

Harris, E. J., Vanore, J. V., Thomas, J. L., et al. (2004) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2004.09.013 · Cited by 241 · see citing works

Clinical Practice Guideline for Soyangin Disease of Sasang Constitutional Medicine: Overview

Lee, E.-J., Koh, B., Kim, D.-R., et al. (2014) · Journal of Sasang Constitutional Medicine · doi:10.7730/jscm.2014.26.3.213 · Cited by 5 · see citing works

What’s new in ADHD diagnosis, treatment?: Clinical practice guideline based on a review of evidence includes companion guide to implementation

Wolraich, M. L. (2011) · AAP News · doi:10.1542/aapnews.20113211-23

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,814 · see citing works